Gosogliptin

DB08382InvestigationalSmall molecule

Gosogliptin has been used in trials studying the treatment of Renal Insufficiency, Chronic.

Chemical structure of Gosogliptin
Mechanism
Curator reviewed
Formula / weight
C17H24F2N6O · 366.4089 g/mol (avg)
Code names
PF-00734200 · PF-734,200

Resolves to

Compound
UNIIGI718UO477CAS869490-23-3ChEMBLCHEMBL515387ChEBI177858PubChem11516136
Structure
InChIKeyQWEWGXUTRTXFRF-KBPBESRZSA-NSMILES[H][C@]1(CN[C@@]([H])(C1)C(=O)N1CCC(F)(F)C1)N1CCN(CC1)C1=NC=CC=N1
Targets
P27487DPP4

What you can answer from here — as of July 18, 2024

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
656Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Gosogliptin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In